TET2 and myelodysplastic syndrome: Conversely, patients with SRSF2 mutations who had a secondary TET2 mutation had similar association with MDS/MPN (SRSF2 followed by dominant TET2; OR 0.43 or vice versa SRSF2 followed by secondary TET2; OR 0.43).